- Brand names:
- Pharmaceutical Company:
- Condition/Indication: SARS-CoV-2 infection
- Meeting Date: November 2023
- Public Summary Document (PSD) November 2023 PBAC Meeting - (PDF 2.2MB)
- Public Summary Document (PSD) November 2023 PBAC Meeting - (Word 1.9MB)
Nirmatrelvir and ritonavir – November 2023
Nirmatrelvir and ritonavir: Pack containing 4 tablets nirmatrelvir 150 mg and 2 tablets ritonavir 100 mg, 5; Paxlovid®
Last updated
1 March 2024